AU2019275599B2 — Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors
Assigned to Array Biopharma Inc · Expires 2020-09-17 · 6y expired
What this patent protects
[00529] Compounds of Formula (I) in which R, R 2, R, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor.
USPTO Abstract
[00529] Compounds of Formula (I) in which R, R 2, R, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.